[250 Pages Report] FMI Analyses Key Pull Factors Translating into the Sluggish Revenue Growth of Point of Care Cholesterol Monitoring Device Market Recently in 2017, FDA approved the SD LipidoCare System launched by SD Biosensor Inc. However, a majority of medical device manufacturers continue to face the challenges to new product launch as a set of …
Author Archives: Editor AN
Peripheral Vascular Stents Market is expected to expand at CAGR of 6.6% over 2022–2028, to reach US$ 5,324.1 Million by 2028 end.
[263 Pages Report] According to the latest market report published by Future Market Insights, titled ‘Peripheral Vascular Stents Market: Global Industry Analysis 2013 – 2021 and Opportunity Assessment 2022 – 2028’, the global peripheral vascular stents market is expected to expand at a CAGR of 6.6% over the forecast period 2022–2028. FMI estimates that the global market for peripheral vascular …
Membrane Microfiltration Market is anticipated to cross US$ 8 Billion by 2028
[242 Pages Report] Several traditional techniques such as pasteurisation, heat treatment, and sterilisation have long been used to improve the shelf life of milk. One of the newest alternatives to heat treatment is microfiltration that reduces bacteria and improves the shelf life of dairy products, while also preserving the basic taste. Adoption of membrane microfiltration …
Continue reading “Membrane Microfiltration Market is anticipated to cross US$ 8 Billion by 2028”
Animal Model Market Key Players – Transposagen Biopharmaceuticals, Inc., Envigo CRS SA, Crown Bioscience, Inc., Eurofins Scientific SE, Genoway SA, Taconic Biosciences, Inc.
[170 Pages Report] According to a recently compiled study by Future Market Insights, the global animal model market will reflect an impressive CAGR through the forecast period, 2017 to 2026. Revenues from the global market for animal model are poised to surpass US$ 2,200 Mn by 2026-end. Leveraging Animal Models offers Better Understanding of Different Diseases Animals …
Implantable Drug-Eluting Devices Market is set to experience a significant growth of 6.0% CAGR from 2022 to 2029
[326 Pages Report] Implantable drug-eluting devices are playing a key role in the management and treatment of various chronic disorders, particularly cardiovascular diseases. Advancements in micro and nanotechnology are aiding key manufacturers to design novel implantable drug-eluting devices. Moreover, controlled and site-specific attributes of implantable drug-eluting devices, further complemented by compatibility with the targeted drug …
Neurovascular Guidewires Market is projected register CAGR of 4.0% during the forecast period 2022-2028
[269 Pages Report] The global demand for neurovascular guidewires will reach the valuation of nearly US$ 280 million in 2022, witnessing an estimated increase of 3.6% over 2022. Over 2022-2028, the global neurovascular guidewires market revenue is likely to expand 1.5X. According to a new research study of Future Market Insights, Straight tip guidewires, with a current …
RFID in Pharmaceuticals Market is envisaged to record a CAGR of over 8% through 2028
Future Market Insights (FMI), in its new study, finds that the radio-frequency identification (RFID) in pharmaceuticals market was valued at over US$ 950 Mn in 2018, and is estimated to register a Y-o-Y growth at approximately 10% in 2019. Prospects remain remarkable for the RFID in pharmaceuticals industry, as efficiency-led actions of players continue to enhance the …
Vulvodynia Treatment Market is expected to register a CAGR of 6.1% over the forecast period of 2022 and 2028.
[246 Pages Report] According to the report, the global vulvodynia treatment market is expected to register a CAGR of 6.1% over the forecast period of 2022 and 2028. The market was worth US$ 4,261.2 Mn in 2021 and is expected to rise to a valuation of US$ 8,091.6 Mn by the end of 2028. Future …
Realtime Bioprocess Raman Analyzer Market to expected to exhibit a CAGR of 14.6% during the forecast period (2020-2030)
The benefits of Raman spectroscopy as data processing in real-time has made significant contribution as a diagnostic and control tool for pharmaceutical production and bioprocessing, with scientific and financial benefits demonstrated throughout the product life cycle. This has led to the growth of real-time bioprocess Raman analyzers market. Future Market Insights (FMI) in a new study …
CMO/CDMO Market exhibiting above 7% CAGR through the forecast period 2020 and 2030
An increasing number of companies within the pharmaceutical sector have been considering contract manufacturing in response to the increasing demand for generic drugs and biologics. In a new study, Future Market Insights (FMI) has forecast the global contract manufacturing/ contract development and manufacturing organization (CMO/ CDMO) market to surpass US$ 18 Bn by 2020. According to the …